相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer's Disease
Jun Yin et al.
MOLECULAR NEUROBIOLOGY (2018)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy
Rong Zhou et al.
MOLECULAR MEDICINE (2018)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling
Jing Qiu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Inflammation and Stroke: An Overview
Josef Anrather et al.
NEUROTHERAPEUTICS (2016)
Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome
Xiangxiang Wang et al.
NEUROSCIENCE LETTERS (2015)
Low doses of the selective adenosine A2A receptor agonist CGS21680 are protective in a rat model of transient cerebral ischemia
Alessia Melani et al.
BRAIN RESEARCH (2014)
Mechanisms and Functions of Inflammasomes
Mohamed Lamkanfi et al.
CELL (2014)
NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke
Fan Yang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis?
Turgay Dalkara et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Microvascular protection is essential for successful neuroprotection in stroke
Yasemin Gursoy-Ozdemir et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
Catarina V. Gomes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Inactivation of Adenosine A2A Receptor Attenuates Basal and Angiotensin II-induced ROS Production by Nox2 in Endothelial Cells
Sapna Thakur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells
Rong Jin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia
Young R. Kim et al.
STROKE (2008)
Adenosine A2A receptors and brain injury:: Broad spectrum of neuroprotection, multifaceted actions and fine tuning modulation
Jiang-Fan Chen et al.
PROGRESS IN NEUROBIOLOGY (2007)
The inflammatory response in stroke
Qing Wang et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury
LQ Yu et al.
NATURE MEDICINE (2004)
The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat
A Melani et al.
BRAIN RESEARCH (2003)
Pharmacology of adenosine A(2A) receptors and therapeutic applications
BB Fredholm et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease
JF Chen et al.
JOURNAL OF NEUROSCIENCE (2001)
分享论文
